Nothing found!
It seems we can’t find what you’re looking for. Perhaps searching can help.
Recent post
Chasing the TB Vaccine
Professor Helen McShane FRCP PhD FMedSci is a leading British infectious disease physician and one of the world’s most influential figures in tuberculosis (TB) vaccine development. A Professor of Vaccinology at the University of Oxford and Director of the NIHR Oxford Biomedical Research Centre, she has dedicated more than two decades to advancing vaccines for some of the world’s most challenging infectious diseases.
Welcome to the Issue 018
Welcome to Vaccines Beat 18th issue! In our Coffee with an Expert section, we had the privilege of speaking with Professor Helen McShane, one of...
Highlights Issue 018
A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.
Latest published papers and commentaries from the chief editors – 018
Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.
Why Every Newborn Needs the Hepatitis B Vaccine at Birth—and the Dangers of Not...
Introduction: Hepatitis B virus (HBV) is the leading cause of chronic viral hepatitis and is a major contributor to acute and chronic liver disease worldwide....






